A detailed history of Bailard, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bailard, Inc. holds 13,386 shares of PRCT stock, worth $1.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,386
Previous 18,386 27.19%
Holding current value
$1.15 Million
Previous $1.12 Million 4.54%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$56.31 - $84.99 $281,550 - $424,950
-5,000 Reduced 27.19%
13,386 $1.07 Million
Q2 2024

Jul 25, 2024

SELL
$45.73 - $69.19 $137,190 - $207,570
-3,000 Reduced 14.03%
18,386 $1.12 Million
Q1 2024

May 08, 2024

BUY
$40.38 - $50.75 $863,566 - $1.09 Million
21,386 New
21,386 $1.06 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.83B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.